BPC 157 And TB 500: Background, Indications, Efficacy, And Safety GlobalRPH BPC 157 Sovereign Health Performance Frontiers Pharmacokinetics, distribution, metabolism, and excretion of body protective compound 157, a potential drug for treating various wounds, in rats and dogs Oral vs Injectable BPC 157: Differences, Benefits, and When to Use Eac Revolution Health & Wellness BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or